Murine terminal deoxynucleotidyl transferase: cellular distribution and response to cortisone.
Author(s) -
Patrick C. Kung,
A E Siverstone,
Ronald P. McCaffrey,
David Baltimore
Publication year - 1975
Publication title -
the journal of experimental medicine
Language(s) - English
Resource type - Journals
eISSN - 1540-9538
pISSN - 0022-1007
DOI - 10.1084/jem.141.4.855
Subject(s) - terminal deoxynucleotidyl transferase , cortisone , thymocyte , population , microbiology and biotechnology , biology , spleen , endocrinology , medicine , chemistry , biochemistry , immunology , tunel assay , antigen , apoptosis , environmental health , cd8
The mouse thymus contains two forms of terminal deoxynucleotidyl transferase (TdT) which are distinguishable by the salt concentration necessary to elute them from a phosphocellulose column, by their distrubtion among the thymocyte subpopulations, and by their sensitivity to cortisone treatment. In the whole thymus the later eluting peak (peak II) is the predominant one with about 3-10% of the total activity appearing in peak I. Both peak I and peak II activities are most sensitively assayed by the polymerization of dGMP onto an oligo(dA) primer. The minor population of thymocytes which is less dense and cortisone-resistant contains a higher specific activity of peak I TdT. The majority of TdT activity is, however, found in the major population of thymocytes which occurs in the center region of a bovine serum albumin gradient and is cortisone-sensitive. A very low level of an activity indistinguishable from peak II TdT activity is also detected in the mouse bone marrow. Other tissues, such as spleen, liver, heart, and brain lack detectable amounts of TdT activity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom